Healthcare - Biotechnology - NASDAQ - US
$ 8.19
-3.87 %
$ 526 M
Market Cap
-19.98
P/E
Price Target
Average
39.19%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
29.80%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Corvus Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for CRVS of $11.4 , with forecasts ranging from a low of $7 to a high of $13 .
CRVS Lowest Price Target
Wall Street Target
7 USD
-14.53%
CRVS Average Price Target
Wall Street Target
11.4 USD
39.19%
CRVS Highest Price Target
Wall Street Target
13 USD
58.73%
REVENUE FORECAST
Revenue Forecast Chart CRVS
EBIT FORECAST
EBIT Forecast Chart CRVS
NET INCOME FORECAST
Net Income Chart CRVS